Новые возможности использования мультиштаммовых синбиотиков в педиатрической практике

Авторы

  • V. V. Berezhnoi
  • V. G. Kozachuk

DOI:

https://doi.org/10.15574/SP.2016.73.33

Ключевые слова:

синбиотики, пробиотические штаммы, дети, Ротабиотик

Аннотация

В статье представлен современный взгляд на микробиоценоз кишечника, роль пробиотических штаммов в коррекции дисбиоза с учетом результатов доказательных клинических исследований. Показана целесообразность применения синбиотиков Ротабиотик и Ротабиотик бэби в профилактике, коррекции дисбиоза при различных патологических состояниях и функциональных расстройствах желудочно-кишечного тракта у детей.

Ключевые слова: синбиотики, пробиотические штаммы, дети, Ротабиотик.

Библиографические ссылки

Andreeva IV. 2011. Sovremennyie dokazatelnyie dannyie effektivnosti primeneniya Lactobacillus Rhamnosus GG i Bifidobacterium Lactis ВB-12 v pediatricheskoy praktike. Vopr sovr pediatrii. 10(1): 50—57.

Abaturov AE, Gerasimenko ON, Vyisochina IL i dr. 2013. Bakteritsidnaya aktivnost probioticheskih sredstv. Zdorove rebenka. 8(51): 95—97.

Berezhniy VV. 2013. PedIatrIya. NatsIonalniy pIdruchnik. Za red prof VV Berezhnogo. KiYiv. TI: 1037.

Voronenko YuV, Shekera OG, Berezhniy VV. 2015. AktualnI pitannya pedIatrIYi v praktitsI sImeynogo lIkarya. Navchalniy posIbnik dlya lIkarIv-InternIv I lIkarIv sluhachIv zakladIv (fakultetIv) pIslyadiplomnoYi osvIti. KiYiv, Vidavets Zaslavskiy OYu: 342.

Doll M. 2007. Probiotiki i ih znachenie dlya organizma. Biologicheskaya meditsina. 13; 1: 11—15.

Zaharov IN, Dmitrieva YuA 2013. Shtamm-spetsificheskie svoystva Bifidobacterium animalis subsp. lactis Bb-12. Pediatriya. 2.

Ivahnenko OS. 2013. EfektivnIst zastosuvannya probIotichnoYi terapIYi u dItey rannogo vIku z harchovoyu alergIEyu. Zdorove rebenka. 6(49): 48—52.

Shadrin OG, Misnik VP, Ponomareva IG, Klimenko LA. 2014. On the question of formation of bowel eubiosis during the artifical infant feefing. Sovremennaya pediatriya. 1(57): 122—127.

Agafonova EA, Petrenko LL, Leonenko NI i dr. 2010. Klinicheskoe i immunologicheskoe znachenie probioticheskoy terapii u detey. Zdorove rebenka. 2(23): 61—64.

Kornienko EA. 2007. Sovremennyie printsipyi vyibora probiotikov. Detskie infektsii. 3: 64—69.

Maev IV, Kucheryavyiy YuA, Andreev DN. 2014. Aktualnyie vozmozhnosti optimizatsii antihelikobakternoy terapii. Lechaschiy vrach. 4: 73—79.

Nikolaeva TN, Zorina VV, Votrin SV. 2007. Analiz vliyaniya probioticheskih shtammov laktobakteriy v podderzhanii immunnogo gomeostaza makroorganizma. Klinicheskoe pitanie. 1-2: 56.

Kornienko EA, Mazankova LN, Belyaeva IA i dr. 2015. Primenenie probiotikov v pediatrii: analiz lechebnogo i profilakticheskogo deystviya s pozitsiy dokazatelnoy meditsinyi. Lechaschiy vrach. 9: 52—61.

Pro zatverdzhennya protokolIv medichnoYi dopomogi dItyam Iz zahvoryuvannyami organIv travlennya. Nakaz MOZ Ukrayini 29.01.2013 № 59. http://www.moz.gov.ua.

Horoshilova NV. 2013. Immunomoduliruyuschee i lechebnoe deystvie bifido- i laktobakteriy u detey s allergicheskimi zabolevaniyami i chastyimi respiratornyimi infektsiyami. Vopr sovr pediatrii. 5: 86—89.

Shvets OV. 2012. Zastosuvannya probIotikIv u gastroenterologIchnIy praktitsI. SImeyna meditsina. 6: 37—42.

Yankovskiy DS. 2005. Mikrobnaya ekologiya cheloveka: sovremennyie vozmozhnosti ee podderzhanie i vosstanovleniya. Kiev, Ekspert LTD: 361.

Shornikova AV, Casas IA, Mykkanen N et al. 1997. Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis. Pediatr Infect Dis J. 16: 1103—1107.

Blyakher МS, Lopatina ТK, Zhukova VM. 2002. Vliyanie Probiotikov na Produktsiyu Interferonov i Limfokinov. Probioticheskie Mikroorganizmy — Sovremennoe Sostoyanie Voprosa i Perspektivy Ispol'zovaniya. The Effect of Probiotics on the Production of Interferons and Lymphokines. Probiotic Microorganisms: The Present State and Prospects of Use. Proceedings of the Conference. Materialy Konferentsii. Moscow: 29.

Gueimonde M, Laitinen K, Salminen S, Isolauri E. 2007. Breast-milk: a symbiotic providing bifidobacteria and bifidogenic substrates for infant gut development and maturation? Abstracts of 40th Annual meeting of the ESPGHAN. PN1—07: 73.

Aloisio I, Santini C, Biavati B et al. 2012. Characterization of Bifidobacterium spp. strains for the treatment of enteric disorders in newborns. Appl Microbiol Biotechnol. 96(6): 1561—76. http://dx.doi.org/10.1007/s00253-012-4138-5. Epub 2012 May 17.

Rossi F, Marzotto M, Cremonese S et al. 2013. Diversity of Streptococcus thermophilus in bacteriocin production; inhibitory spectrum and occurrence of thermophilin genes. Food Microbiol. 35(1): 27—33. http://dx.doi.org/10.1016/j.fm.2013.02.006

Whonwell PJ, Altringer L et. al. 2006. Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with imitable dowel syndrome. Am J Gastroenterol. 101: 1581—1590.

Gronlund MM, Lehtonen OP, Eerola E, Kepo PJ. 1999. Fecal microflora in healthy infants born by different methods of delivery. Pediatr Gastroenterol Nutr. 28: 19—25.

Gill H, Prasad J. 2008. Probiotics, immunomodulation, and health benefits. Adv Exp Med Biol. 606: 423—547.

Novak FR, Almeida JAG, Vieira GO, Borba LM. 2001. Human colostrum: a natural source of probiotics? J Pediatr. 77(4): 265—270.

Abedi D, Feizizadeh S, Akbari V, Jafarian-Dehkordi A. 2013. In vitro antibacterial and anti-adherence effects of Lactobacillus delbrueckii subsp bulgaricus on Escherichia coli. Res Pharm Sci. 8(4): 260—8.

Shimazaki Y, Shirota T, Uchida K et al. 2008. Intake of dairy product and periodontal diseases: The hisayama study. J Periodontol. 79: 131—137.

Jonkers D, Stockbrugger R. 2007. Review article: Probiotics in gastrointestinal and liver diseases. Pharmacol Ther. 26; Suppl 2: 133—48.

Kligler B. 2008. Cohrss Aliment Pharmacol Theren A. Probiotics. Am Fam Physician. 78: 1073—1078.

Timmerman HM, Koning CJM, Mulder L et al. 2004. Monostrein, multistrein and multispecies probiotics. Int J Food Microbiol. 96: 219—233.

Ohland CL, Macnaughton WK. 2010. Probiotic bacteria and ontestinal erithelial barrier function. Am J Physiol Gastrointest Liver Physiol. 298; 6: G807—G819. doi: 10/1152/ajpgi-00243.2009.

Senok AC et al. 2005. Probiotics: facts and myths. Clin Micr And Inf. 11; 12: 958—966.

Dunne C, Murphy L, Flynn S et al. 1999. Probiotics: from myth to reality. Demonstration of functionality in animal models of disease and in human clinical trials. Antonie Van Leeuwenhoek. 76: 279—292.

Proceedings of the International Scientific Conference on Probiotics and Prebiotics YPC2010. Kosice, Slovakia. 2010: 15.

Mkrtchyan H, Gibbons S, Heidelberger S et al. 2010. Purification, characterisation and identification of acidocin LCHV, an antimicrobial peptide produced by Lactobacillus acidophilus n.v. Er 317/402 strain Narine. Int J Antimicrob Agents. 35(3): 255—60; http://dx.doi.org/10.1016/j.ijantimicag.2009.11.017.

Renye JAJr., Somkuti GA. 2013. BlpC-regulated bacteriocin production in Streptococcus thermophiles. Biotechnol Lett. 35(3): 407—12. http://dx.doi.org/10.1007/s10529-012-1095-0.

Rerksuppaphol S, Rerksuppaphol L. 2012. Randomized controlled trial of probiotics to reduce common cold in schoolchildren. Pediatr Int. 54(5): 682—687. http://dx.doi.org/10.1111/j.1442-200X.2012.03647.x; PMid:22507276

Rolfe RD. 2000. The role of probiotic cultures in the control of gastrointestinal health. J Nutr. 130; Suppl 2: 396—402.

Rusch K, Peters U. 2002. Der Darm — zentrale des immunsystems. Biol Med. 4: 176—180.

Salminen MK et al. 2006. Clin Inf Dis. 42: 35—44.

Sanders ME, Huisin't Veld J. 1999. Bringing a probiotic-containing functional food to the market: microbiological, product, regulatory and labeling issues. Antonie Van Leeuwenhoek. 76: 293—315.

Kianifar H, Ahanchian H, Grover Z et al. 2014. Synbiotic in the management of infantile colic: a randomised controlled trial. Paediаtrics Child Health. 50(10): 801—5; http://dx.doi.org/10.1111/jpc.12640. Epub 2014 Jun 24.

Szajewska H, Horvath A, Piwowarczyk A. 2010. Meta-analysis: the effects of Saccharomyces boulardii supplementation on Helicobacter pylori eradication rates and side effects during treatment. Aliment Pharmacol Ther. 32(9): 1069—1079. http://dx.doi.org/10.1111/j.1365-2036.2010.04457.x; PMid:21039671

Wang ZH, Gao QY, Fang JY. 2013. Meta-Analysis of the Efficacy and safety of Lactobacillus-containing and Bifidobacterium-containing probiotic compound preparation in Helicobacter pylori eradication therapy. J Clin Gastroenterol. 47(1): 25—32. http://dx.doi.org/10.1097/MCG.0b013e318266f6cf; PMid:23090045

Zou J, Dong J, Yu X. 2009. Meta-analysis: Lactobacillus containing quadruple therapy versus standard triple first-line therapy for Helicobacter pylori eradication. Helicobacter. 14(5): 97—107. http://dx.doi.org/10.1111/j.1523-5378.2009.00716.x; PMid:19751434

Выпуск

Раздел

Актуальные вопросы педиатрии